Fibrogenex, Inc.

Chicago, IL 60612

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $0.0
First Award Date 08/14/90
Most Recent Award Date 09/30/92

Key Personnel

Last Name Name Awards Contact
Goodheart Clyde Goodheart 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/92 - 09/30/93

DESCRIPTION: (Adapted from the applicant's abstract) The long-term objectives of the proposed research are to determine the efficacy of solubilized components of the leptomeningeal extracellular matrix in treating malignant brain tumors. Phase I feasibility studies will concentrate on 1) preparing and characterizing fibronectin from human lept...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/14/90 - 03/31/91

The long-term objectives of the research are to determine the efficacy of cellular fibronectin in preventing implantation of metastatic tumor cells at surgical incisions. Phase I feasibility studies will be in mice, using a model for metastatic implants developed at Evanston Hospital. Sufficient cellular fibronectin will be produced and purifi...